(TheNewswire)


Fusion Nutrition Inc. (“FUSION”), a leading sports nutrition company founded in 1998 and a recent acquisition of Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (“Sire” or the “Company”) is pleased to announce appointments of its new Director of International Sales, Brad Baker, and its new Director of Canadian Sales, Robin Barkhouse, both effective immediately

Brad Baker is an elite-level global Sales & Marketing professional who has spent the last 20+ years making his mark on the global fitness industry. He logged a 16-year tenure at Iovate Health Sciences, both as an original MuscleTech athlete and delivering great success managing their US Distributor Channel and US National Field Team. During such tenure, Mr. Baker also hit the marketing and brand jackpot as the marketing architect in delivering Iovate an Indy 500 Championship Win as a primary sponsor in the inaugural season of the program. He is widely considered a pillar of respect in the fitness industry. With integrity and passion in lockstep with every decision made, Mr. Baker is fearless and yet strategic with every effort put forth, resulting in success time and time again.

“My professional life has always been defined by the successful pivot at the right, precise moment. SIRE presented me its people first–extraordinary, elite-level professionals and top performers whom you would be willing to go to war with on a moment’s notice and come out victorious. Then, I was introduced to its brand, Fusion,” said Baker. “Words like integrity, original, dynamic, strategic, and limitless immediately come to mind when describing Fusion and the people of Sire in unison. Talent is like a muscle–you either have it, or you don’t. When you combine talented people with an integral brand of an industry such as Fusion, you create an unstoppable momentum of success. I can honestly say, the very best is yet to come.”

Robin Barkhouse has 23 years of experience in the sports nutrition industry focused on the Canadian market. He started at Toronto-based Health Body Services Inc., where he stayed for 14 years and helped roll out the AllMax Nutrition brand. Very well respected in the sports supplement world in Canada, Mr. Barkhouse’s key to success in this industry is the individual attention he gives to customers. He enjoys taking care of their specific needs while nurturing relationships over the years of doing business together.

“I’m very excited about my role with Fusion as the Director of Canadian Sales. Fusion has been around since 1998, and I’m so pleased to be part of a very well respected company in our space. The industry is changing fast and now, under the SIRE umbrella, it’s such an exciting opportunity to possibly be the first company to have legal CBD in sports supplements,” said Barkhouse.

About Fusion Nutrition Inc.
Website: fusionmuscle.com
Socials: @fusionmuscle

Founded in 1998, FUSION is a Canadian-based, leading supplement company with national distribution. It currently hosts multiple brands, including some of the fastest-growing supplements in Canada and numerous category leaders sold in Canada’s top five retailers. FUSION products are developed using the latest research available to provide maximum efficacy by supporting the human body in its own natural processes.

About Sire Bioscience Inc .
Website:
sirebioscience.com
Socials: @sirebioscience

SIRE’s principal business activity is to engage in the investment, production of, development of hemp, CBD, and non-CBD products. SIRE has its wholly-owned facility in Leamington, Ontario. The land parcel includes 50 acres of prime horticultural land, with a 160,000 sq. ft. facility of combined greenhouse and indoor space. SIRE’s goal is to become a vertically integrated CPG life science company with its “House of Brands” offering. SIRE is headquartered in Mississauga, Ontario, and is managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer packaged goods, manufacturing, logistics, and distribution.

FOR INFORMATION, CONTACT:
Sire Bioscience Inc.
E: ir@sirebioscience.com

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Information Cautionary Statement

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading “Risks Factors” in the Company’s Listing Statement dated August 22, 2019 and filed on the Company’s SEDAR profile. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

Copyright (c) 2020 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less